Title 40

PART 799

Part 799 - Identification Of Specific Chemical Substance And Mixture Testing Requirements

PART 799 - IDENTIFICATION OF SPECIFIC CHEMICAL SUBSTANCE AND MIXTURE TESTING REQUIREMENTS Authority:15 U.S.C. 2603, 2611, 2625. Source:49 FR 39817, Oct. 10, 1984, unless otherwise noted.

40:35.0.1.1.8.1SUBPART A
Subpart A - General Provisions
40:35.0.1.1.8.1.1.1SECTION 799.1
   799.1 Scope and purpose.
40:35.0.1.1.8.1.1.2SECTION 799.2
   799.2 Applicability.
40:35.0.1.1.8.1.1.3SECTION 799.3
   799.3 Definitions.
40:35.0.1.1.8.1.1.4SECTION 799.5
   799.5 Submission of information.
40:35.0.1.1.8.1.1.5SECTION 799.10
   799.10 Test standards.
40:35.0.1.1.8.1.1.6SECTION 799.11
   799.11 Availability of test guidelines.
40:35.0.1.1.8.1.1.7SECTION 799.12
   799.12 Test results.
40:35.0.1.1.8.1.1.8SECTION 799.17
   799.17 Effects of non-compliance.
40:35.0.1.1.8.1.1.9SECTION 799.18
   799.18 Chemicals subject of test rules or consent orders for which the testing reimbursement period has passed.
40:35.0.1.1.8.1.1.10SECTION 799.19
   799.19 Chemical imports and exports.
40:35.0.1.1.8.2SUBPART B
Subpart B - Specific Chemical Test Rules
40:35.0.1.1.8.2.1.1SECTION 799.1053
   799.1053 Trichlorobenzenes.
40:35.0.1.1.8.2.1.2SECTION 799.1560
   799.1560 Diethylene glycol butyl ether and diethylene glycol butyl ether acetate.
40:35.0.1.1.8.2.1.3SECTION 799.1575
   799.1575 Diethylenetriamine (DETA).
40:35.0.1.1.8.2.1.4SECTION 799.1645
   799.1645 2-Ethylhexanol.
40:35.0.1.1.8.2.1.5SECTION 799.1700
   799.1700 Fluoroalkenes.
40:35.0.1.1.8.2.1.6SECTION 799.2155
   799.2155 Commercial hexane.
40:35.0.1.1.8.2.1.7SECTION 799.2325
   799.2325 Isopropanol.
40:35.0.1.1.8.2.1.8SECTION 799.2475
   799.2475 2-Mercaptobenzothiazole.
40:35.0.1.1.8.2.1.9SECTION 799.2700
   799.2700 Methyl ethyl ketoxime.
40:35.0.1.1.8.2.1.10SECTION 799.3300
   799.3300 Unsubstituted phenylenediamines.
40:35.0.1.1.8.2.1.11SECTION 799.4360
   799.4360 Tributyl phosphate.
40:35.0.1.1.8.2.1.12SECTION 799.4440
   799.4440 Triethylene glycol monomethyl ether.
40:35.0.1.1.8.3SUBPART C
Subpart C - Testing Consent Orders
40:35.0.1.1.8.3.1.1SECTION 799.5000
   799.5000 Testing consent orders for substances and mixtures with Chemical Abstract Service Registry Numbers.
40:35.0.1.1.8.3.1.2SECTION 799.5025
   799.5025 Testing consent orders for mixtures without Chemical Abstracts Service Registry Numbers.
40:35.0.1.1.8.4SUBPART D
Subpart D - Multichemical Test Rules
40:35.0.1.1.8.4.1.1SECTION 799.5055
   799.5055 Hazardous waste constituents subject to testing.
40:35.0.1.1.8.4.1.2SECTION 799.5075
   799.5075 Drinking water contaminants subject to testing.
40:35.0.1.1.8.4.1.3SECTION 799.5085
   799.5085 Chemical testing requirements for first group of high production volume chemicals (HPV1).
40:35.0.1.1.8.4.1.4SECTION 799.5087
   799.5087 Chemical testing requirements for second group of high production volume chemicals (HPV2).
40:35.0.1.1.8.4.1.5SECTION 799.5089
   799.5089 Chemical testing requirements for third group of high production volume chemicals (HPV3).
40:35.0.1.1.8.4.1.6SECTION 799.5115
   799.5115 Chemical testing requirements for certain chemicals of interest to the Occupational Safety and Health Administration.
40:35.0.1.1.8.5SUBPART E
Subpart E - Product Properties Test Guidelines
40:35.0.1.1.8.5.1.1SECTION 799.6755
   799.6755 TSCA partition coefficient (n-octanol/water), shake flask method.
40:35.0.1.1.8.5.1.2SECTION 799.6756
   799.6756 TSCA partition coefficient (n-octanol/water), generator column method.
40:35.0.1.1.8.5.1.3SECTION 799.6784
   799.6784 TSCA water solubility: Column elution method; shake flask method.
40:35.0.1.1.8.5.1.4SECTION 799.6786
   799.6786 TSCA water solubility: Generator column method.
40:35.0.1.1.8.6SUBPART F
Subparts F-G [Reserved]
40:35.0.1.1.8.7SUBPART H
Subpart H - Health Effects Test Guidelines
40:35.0.1.1.8.7.1.1SECTION 799.9110
   799.9110 TSCA acute oral toxicity.
40:35.0.1.1.8.7.1.2SECTION 799.9120
   799.9120 TSCA acute dermal toxicity.
40:35.0.1.1.8.7.1.3SECTION 799.9130
   799.9130 TSCA acute inhalation toxicity.
40:35.0.1.1.8.7.1.4SECTION 799.9135
   799.9135 TSCA acute inhalation toxicity with histopathology.
40:35.0.1.1.8.7.1.5SECTION 799.9305
   799.9305 TSCA Repeated dose 28-day oral toxicity study in rodents.
40:35.0.1.1.8.7.1.6SECTION 799.9310
   799.9310 TSCA 90-day oral toxicity in rodents.
40:35.0.1.1.8.7.1.7SECTION 799.9325
   799.9325 TSCA 90-day dermal toxicity.
40:35.0.1.1.8.7.1.8SECTION 799.9346
   799.9346 TSCA 90-day inhalation toxicity.
40:35.0.1.1.8.7.1.9SECTION 799.9355
   799.9355 TSCA reproduction/developmental toxicity screening test.
40:35.0.1.1.8.7.1.10SECTION 799.9365
   799.9365 TSCA combined repeated dose toxicity study with the reproduction/developmental toxicity screening test.
40:35.0.1.1.8.7.1.11SECTION 799.9370
   799.9370 TSCA prenatal developmental toxicity.
40:35.0.1.1.8.7.1.12SECTION 799.9380
   799.9380 TSCA reproduction and fertility effects.
40:35.0.1.1.8.7.1.13SECTION 799.9410
   799.9410 TSCA chronic toxicity.
40:35.0.1.1.8.7.1.14SECTION 799.9420
   799.9420 TSCA carcinogenicity.
40:35.0.1.1.8.7.1.15SECTION 799.9430
   799.9430 TSCA combined chronic toxicity/carcinogenicity.
40:35.0.1.1.8.7.1.16SECTION 799.9510
   799.9510 TSCA bacterial reverse mutation test.
40:35.0.1.1.8.7.1.17SECTION 799.9530
   799.9530 TSCA in vitro mammalian cell gene mutation test.
40:35.0.1.1.8.7.1.18SECTION 799.9537
   799.9537 TSCA in vitro mammalian chromosome aberration test.
40:35.0.1.1.8.7.1.19SECTION 799.9538
   799.9538 TSCA mammalian bone marrow chromosomal aberration test.
40:35.0.1.1.8.7.1.20SECTION 799.9539
   799.9539 TSCA mammalian erythrocyte micronucleus test.
40:35.0.1.1.8.7.1.21SECTION 799.9620
   799.9620 TSCA neurotoxicity screening battery.
40:35.0.1.1.8.7.1.22SECTION 799.9630
   799.9630 TSCA developmental neurotoxicity.
40:35.0.1.1.8.7.1.23SECTION 799.9748
   799.9748 TSCA metabolism and pharmacokinetics
40:35.0.1.1.8.7.1.24SECTION 799.9780
   799.9780 TSCA immunotoxicity.